Citadel Advisors - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$16,769
-22.4%
18,159
-36.3%
0.00%
Q1 2023$21,617
-81.1%
28,500
-37.6%
0.00%
Q4 2022$114,574
-9.8%
45,647
-50.4%
0.00%
Q3 2022$127,000
+30.9%
92,025
+19.4%
0.00%
Q2 2022$97,000
-25.4%
77,074
+51.2%
0.00%
Q3 2021$130,000
+306.2%
50,981
+351.2%
0.00%
Q2 2021$32,000
-87.1%
11,300
-85.9%
0.00%
Q1 2021$249,000
+479.1%
79,908
+384.0%
0.00%
Q4 2020$43,000
-35.8%
16,511
-3.3%
0.00%
Q2 2019$67,00017,0780.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 250,518$722,0000.59%
Nantahala Capital Management 990,655$2,853,0000.09%
GSA CAPITAL PARTNERS LLP 82,421$237,0000.04%
FEDERATED HERMES, INC. 117,673$339,0000.00%
BNP PARIBAS FINANCIAL MARKETS 179$516,0000.00%
Horan Securities, Inc. 24$00.00%
OSAIC HOLDINGS, INC. 200$1,0000.00%
BANK OF AMERICA CORP /DE/ 3$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 31,083$90,0000.00%
View complete list of ACER THERAPEUTICS INC shareholders